fanta.bio Sample: CNhs11910
16265 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1022 / 11152 (9.2%) | 308 / 111520 (0.3%) | −324.0 | −324.0 | 33.18 |
| HIF1A SRX11007095 | HK-2 Kidney | 1940 / 11152 (17.4%) | 673 / 111520 (0.6%) | −324.0 | −324.0 | 28.83 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1496 / 11152 (13.4%) | 538 / 111520 (0.5%) | −324.0 | −324.0 | 27.81 |
| TP53 SRX19538279 | Osteoblasts Bone | 471 / 11152 (4.2%) | 191 / 111520 (0.2%) | −324.0 | −324.0 | 24.66 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1364 / 11152 (12.2%) | 576 / 111520 (0.5%) | −324.0 | −324.0 | 23.68 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1879 / 11152 (16.8%) | 883 / 111520 (0.8%) | −324.0 | −324.0 | 21.28 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1822 / 11152 (16.3%) | 882 / 111520 (0.8%) | −324.0 | −324.0 | 20.66 |
| SCML2 SRX644728 | 293 Kidney | 1105 / 11152 (9.9%) | 541 / 111520 (0.5%) | −324.0 | −324.0 | 20.43 |
| MYH11 SRX265221 | ME-1 Blood | 677 / 11152 (6.1%) | 436 / 111520 (0.4%) | −324.0 | −324.0 | 15.53 |
| FOXP1 SRX736067 | LNCAP Prostate | 1267 / 11152 (11.4%) | 900 / 111520 (0.8%) | −324.0 | −324.0 | 14.08 |
| BRD4 SRX9419935 | BT-474 Breast | 2715 / 11152 (24.3%) | 2060 / 111520 (1.8%) | −324.0 | −324.0 | 13.18 |
| MED1 SRX9419944 | BT-474 Breast | 2608 / 11152 (23.4%) | 2029 / 111520 (1.8%) | −324.0 | −324.0 | 12.85 |
| BRD4 SRX9419937 | BT-474 Breast | 2691 / 11152 (24.1%) | 2100 / 111520 (1.9%) | −324.0 | −324.0 | 12.81 |
| MED1 SRX9419945 | BT-474 Breast | 2647 / 11152 (23.7%) | 2066 / 111520 (1.9%) | −324.0 | −324.0 | 12.81 |
| BRD4 SRX9419936 | BT-474 Breast | 2725 / 11152 (24.4%) | 2156 / 111520 (1.9%) | −324.0 | −324.0 | 12.64 |
| MED1 SRX9419946 | BT-474 Breast | 2719 / 11152 (24.4%) | 2185 / 111520 (2.0%) | −324.0 | −324.0 | 12.44 |
| BRD4 SRX9419938 | BT-474 Breast | 2695 / 11152 (24.2%) | 2170 / 111520 (1.9%) | −324.0 | −324.0 | 12.42 |
| MED1 SRX9419947 | BT-474 Breast | 2602 / 11152 (23.3%) | 2127 / 111520 (1.9%) | −324.0 | −324.0 | 12.23 |
| BRD4 SRX736201 | 90-8TL Neural | 4491 / 11152 (40.3%) | 4663 / 111520 (4.2%) | −324.0 | −324.0 | 9.63 |
| EZH2 SRX2146136 | LNCAP Prostate | 5598 / 11152 (50.2%) | 5854 / 111520 (5.2%) | −324.0 | −324.0 | 9.56 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1371 / 11152 (12.3%) | 1907 / 111520 (1.7%) | −324.0 | −324.0 | 7.19 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1169 / 11152 (10.5%) | 2398 / 111520 (2.2%) | −324.0 | −324.0 | 4.87 |
| AGO2 SRX4708039 | Hep G2 Liver | 1576 / 11152 (14.1%) | 4891 / 111520 (4.4%) | −308.6 | −305.4 | 3.22 |
| TP53 SRX19538274 | U2OS Bone | 390 / 11152 (3.5%) | 113 / 111520 (0.1%) | −298.4 | −295.2 | 34.51 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1264 / 11152 (11.3%) | 3378 / 111520 (3.0%) | −293.6 | −290.5 | 3.74 |
| TP53 SRX19538276 | U2OS Bone | 390 / 11152 (3.5%) | 124 / 111520 (0.1%) | −291.9 | −288.8 | 31.45 |
| TP53 SRX19538268 | U2OS Bone | 380 / 11152 (3.4%) | 124 / 111520 (0.1%) | −282.5 | −279.4 | 30.65 |
| HIF1A SRX20663235 | HK-2 Kidney | 414 / 11152 (3.7%) | 188 / 111520 (0.2%) | −280.8 | −277.7 | 22.02 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 562 / 11152 (5.0%) | 601 / 111520 (0.5%) | −266.5 | −263.4 | 9.35 |
| PBX4 SRX2731658 | PC-3 Prostate | 529 / 11152 (4.7%) | 17352 / 111520 (15.6%) | −264.6 | −261.5 | 0.30 |
| TP53 SRX19538267 | U2OS Bone | 347 / 11152 (3.1%) | 109 / 111520 (0.1%) | −260.3 | −257.3 | 31.83 |
| TP53 SRX19538280 | Osteoblasts Bone | 368 / 11152 (3.3%) | 146 / 111520 (0.1%) | −259.7 | −256.7 | 25.21 |
| IRF3 SRX11453858 | Hep G2 Liver | 302 / 11152 (2.7%) | 51 / 111520 (0.0%) | −256.1 | −253.1 | 59.22 |
| RUNX1 SRX2513054 | 293 Kidney | 2513 / 11152 (22.5%) | 11831 / 111520 (10.6%) | −254.6 | −251.6 | 2.12 |
| TP53 SRX19538281 | Osteoblasts Bone | 392 / 11152 (3.5%) | 205 / 111520 (0.2%) | −253.8 | −250.9 | 19.12 |
| TP53 SRX19538273 | U2OS Bone | 339 / 11152 (3.0%) | 111 / 111520 (0.1%) | −251.7 | −248.8 | 30.54 |
| TP53 SRX19538269 | U2OS Bone | 424 / 11152 (3.8%) | 293 / 111520 (0.3%) | −247.3 | −244.4 | 14.47 |
| TP53 SRX19538275 | U2OS Bone | 345 / 11152 (3.1%) | 132 / 111520 (0.1%) | −245.9 | −243.0 | 26.14 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 528 / 11152 (4.7%) | 601 / 111520 (0.5%) | −241.4 | −238.5 | 8.79 |
| KAT6A SRX20971022 | Fibroblasts Others | 278 / 11152 (2.5%) | 48 / 111520 (0.0%) | −234.9 | −231.9 | 57.92 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 345 / 11152 (3.1%) | 163 / 111520 (0.1%) | −230.9 | −228.0 | 21.17 |
| TP53 SRX19538270 | U2OS Bone | 398 / 11152 (3.6%) | 285 / 111520 (0.3%) | −228.7 | −225.8 | 13.96 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1649 / 11152 (14.8%) | 6446 / 111520 (5.8%) | −228.2 | −225.4 | 2.56 |
| FOS SRX150477 | MCF 10A Breast | 339 / 11152 (3.0%) | 12921 / 111520 (11.6%) | −221.6 | −218.7 | 0.26 |
| IRF3 SRX11453861 | Hep G2 Liver | 264 / 11152 (2.4%) | 48 / 111520 (0.0%) | −221.1 | −218.3 | 55.00 |
| FOS SRX150478 | MCF 10A Breast | 360 / 11152 (3.2%) | 13266 / 111520 (11.9%) | −221.0 | −218.2 | 0.27 |
| 5-mC SRX882970 | LNCAP Prostate | 2153 / 11152 (19.3%) | 10218 / 111520 (9.2%) | −209.3 | −206.4 | 2.11 |
| TP53 SRX19538271 | U2OS Bone | 541 / 11152 (4.9%) | 800 / 111520 (0.7%) | −209.2 | −206.3 | 6.76 |
| BRD4 SRX736204 | 90-8TL Neural | 793 / 11152 (7.1%) | 1862 / 111520 (1.7%) | −208.2 | −205.4 | 4.26 |
| YAP1 SRX757325 | H2052 Lung | 394 / 11152 (3.5%) | 13413 / 111520 (12.0%) | −207.1 | −204.2 | 0.29 |
| YAP1 SRX757326 | H2052 Lung | 313 / 11152 (2.8%) | 12028 / 111520 (10.8%) | −206.7 | −203.8 | 0.26 |
| 5-mC SRX882968 | LNCAP Prostate | 2125 / 11152 (19.1%) | 10083 / 111520 (9.0%) | −206.3 | −203.5 | 2.11 |
| CIC SRX13262055 | Astrocytes Neural | 2266 / 11152 (20.3%) | 11118 / 111520 (10.0%) | −205.5 | −202.7 | 2.04 |
| TP53 SRX19538282 | Osteoblasts Bone | 334 / 11152 (3.0%) | 209 / 111520 (0.2%) | −202.5 | −199.7 | 15.98 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 497 / 11152 (4.5%) | 692 / 111520 (0.6%) | −200.1 | −197.4 | 7.18 |
| AGO2 SRX6783957 | Hep G2 Liver | 993 / 11152 (8.9%) | 2978 / 111520 (2.7%) | −198.1 | −195.4 | 3.33 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 352 / 11152 (3.2%) | 12384 / 111520 (11.1%) | −196.3 | −193.5 | 0.28 |
| Epitope tags SRX10549776 | K-562 Blood | 1082 / 11152 (9.7%) | 3499 / 111520 (3.1%) | −195.8 | −193.0 | 3.09 |
| BRD1 SRX286203 | RKO Digestive tract | 929 / 11152 (8.3%) | 2664 / 111520 (2.4%) | −195.7 | −192.9 | 3.49 |
| AGO2 SRX6783958 | Hep G2 Liver | 962 / 11152 (8.6%) | 2860 / 111520 (2.6%) | −193.9 | −191.1 | 3.36 |
| KAT7 SRX101303 | RKO Digestive tract | 1045 / 11152 (9.4%) | 3352 / 111520 (3.0%) | −190.9 | −188.2 | 3.12 |
| FOS SRX4192880 | MCF 10A Breast | 252 / 11152 (2.3%) | 10464 / 111520 (9.4%) | −190.2 | −187.5 | 0.24 |
| 5-mC SRX882965 | LNCAP Prostate | 1746 / 11152 (15.7%) | 7887 / 111520 (7.1%) | −184.4 | −181.7 | 2.21 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1072 / 11152 (9.6%) | 3610 / 111520 (3.2%) | −182.9 | −180.2 | 2.97 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 915 / 11152 (8.2%) | 2743 / 111520 (2.5%) | −182.1 | −179.4 | 3.34 |
| FOXA1 SRX4815198 | MCF-7 Breast | 619 / 11152 (5.6%) | 16094 / 111520 (14.4%) | −181.9 | −179.2 | 0.38 |
| AR SRX10820653 | LNCAP Prostate | 277 / 11152 (2.5%) | 148 / 111520 (0.1%) | −177.9 | −175.2 | 18.72 |
| FOXA1 SRX4815197 | MCF-7 Breast | 433 / 11152 (3.9%) | 13086 / 111520 (11.7%) | −176.6 | −173.9 | 0.33 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 390 / 11152 (3.5%) | 450 / 111520 (0.4%) | −176.5 | −173.8 | 8.67 |
| BRPF3 SRX796084 | RKO Digestive tract | 1130 / 11152 (10.1%) | 4067 / 111520 (3.6%) | −174.7 | −172.0 | 2.78 |
| BRPF3 SRX796086 | RKO Digestive tract | 1092 / 11152 (9.8%) | 3843 / 111520 (3.4%) | −174.6 | −171.9 | 2.84 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1245 / 11152 (11.2%) | 4790 / 111520 (4.3%) | −173.5 | −170.8 | 2.60 |
| SREBF2 SRX5359048 | HCC70 Breast | 1279 / 11152 (11.5%) | 5031 / 111520 (4.5%) | −171.8 | −169.2 | 2.54 |
| TRP47 SRX4548329 | THP-1 Blood | 1908 / 11152 (17.1%) | 9303 / 111520 (8.3%) | −171.5 | −168.9 | 2.05 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 230 / 11152 (2.1%) | 74 / 111520 (0.1%) | −171.4 | −168.8 | 31.08 |
| BRPF3 SRX796085 | RKO Digestive tract | 816 / 11152 (7.3%) | 2386 / 111520 (2.1%) | −167.0 | −164.4 | 3.42 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1288 / 11152 (11.5%) | 5174 / 111520 (4.6%) | −166.7 | −164.1 | 2.49 |
| FOXA1 SRX176862 | MCF-7 Breast | 220 / 11152 (2.0%) | 9181 / 111520 (8.2%) | −166.3 | −163.7 | 0.24 |
| FOXA1 SRX3931044 | MCF-7 Breast | 397 / 11152 (3.6%) | 12085 / 111520 (10.8%) | −163.4 | −160.8 | 0.33 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1344 / 11152 (12.1%) | 5601 / 111520 (5.0%) | −163.0 | −160.4 | 2.40 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1282 / 11152 (11.5%) | 5252 / 111520 (4.7%) | −160.1 | −157.5 | 2.44 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1395 / 11152 (12.5%) | 6002 / 111520 (5.4%) | −159.5 | −156.9 | 2.32 |
| FOS SRX150517 | MCF 10A Breast | 310 / 11152 (2.8%) | 10530 / 111520 (9.4%) | −159.2 | −156.6 | 0.29 |
| FOS SRX150476 | MCF 10A Breast | 311 / 11152 (2.8%) | 10514 / 111520 (9.4%) | −158.1 | −155.5 | 0.30 |
| RUNX1 SRX2014504 | Jurkat Blood | 1741 / 11152 (15.6%) | 8425 / 111520 (7.6%) | −157.8 | −155.2 | 2.07 |
| TP53 SRX396254 | Fibroblasts Others | 684 / 11152 (6.1%) | 1804 / 111520 (1.6%) | −157.8 | −155.2 | 3.79 |
| FOXA1 SRX1161177 | MCF-7 Breast | 167 / 11152 (1.5%) | 7926 / 111520 (7.1%) | −157.2 | −154.6 | 0.21 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 221 / 11152 (2.0%) | 8891 / 111520 (8.0%) | −156.0 | −153.4 | 0.25 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1399 / 11152 (12.5%) | 6111 / 111520 (5.5%) | −155.2 | −152.6 | 2.29 |
| TP53 SRX19538272 | U2OS Bone | 443 / 11152 (4.0%) | 747 / 111520 (0.7%) | −155.1 | −152.5 | 5.93 |
| GATA3 SRX190239 | MCF-7 Breast | 278 / 11152 (2.5%) | 9856 / 111520 (8.8%) | −155.0 | −152.4 | 0.28 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1155 / 11152 (10.4%) | 4536 / 111520 (4.1%) | −154.5 | −151.9 | 2.55 |
| ING5 SRX286202 | RKO Digestive tract | 965 / 11152 (8.7%) | 3393 / 111520 (3.0%) | −153.6 | −151.1 | 2.84 |
| MITF SRX1555436 | 501A Epidermis | 1422 / 11152 (12.8%) | 6303 / 111520 (5.7%) | −153.3 | −150.8 | 2.26 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 208 / 11152 (1.9%) | 8573 / 111520 (7.7%) | −153.3 | −150.7 | 0.24 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 207 / 11152 (1.9%) | 8554 / 111520 (7.7%) | −153.2 | −150.6 | 0.24 |
| FOXA1 SRX176863 | MCF-7 Breast | 220 / 11152 (2.0%) | 8789 / 111520 (7.9%) | −153.1 | −150.6 | 0.25 |
| BMI1 SRX7196721 | SF8628 Neural | 1247 / 11152 (11.2%) | 5160 / 111520 (4.6%) | −152.5 | −149.9 | 2.42 |
| AR SRX10820651 | LNCAP Prostate | 280 / 11152 (2.5%) | 227 / 111520 (0.2%) | −152.2 | −149.6 | 12.33 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 375 / 11152 (3.4%) | 516 / 111520 (0.5%) | −151.9 | −149.4 | 7.27 |
| FOXA1 SRX371482 | MCF-7 Breast | 280 / 11152 (2.5%) | 9717 / 111520 (8.7%) | −149.4 | −146.9 | 0.29 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 477 / 11152 (4.3%) | 925 / 111520 (0.8%) | −148.8 | −146.3 | 5.16 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 271 / 11152 (2.4%) | 9522 / 111520 (8.5%) | −148.0 | −145.5 | 0.28 |
| TLE3 SRX4815191 | MCF-7 Breast | 170 / 11152 (1.5%) | 7692 / 111520 (6.9%) | −147.2 | −144.7 | 0.22 |
| JUNB SRX8488088 | SUM 229PE Breast | 378 / 11152 (3.4%) | 11236 / 111520 (10.1%) | −146.9 | −144.4 | 0.34 |
| AR SRX1067071 | LHSAR Prostate | 398 / 11152 (3.6%) | 11544 / 111520 (10.4%) | −146.7 | −144.2 | 0.34 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 331 / 11152 (3.0%) | 10475 / 111520 (9.4%) | −146.6 | −144.1 | 0.32 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1477 / 11152 (13.2%) | 6820 / 111520 (6.1%) | −146.5 | −144.0 | 2.17 |
| FOS SRX4192879 | MCF 10A Breast | 206 / 11152 (1.8%) | 8323 / 111520 (7.5%) | −146.0 | −143.5 | 0.25 |
| FOXA1 SRX1161176 | MCF-7 Breast | 174 / 11152 (1.6%) | 7717 / 111520 (6.9%) | −145.4 | −142.9 | 0.23 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 609 / 11152 (5.5%) | 1564 / 111520 (1.4%) | −144.5 | −142.0 | 3.89 |
| ESR1 SRX371478 | MCF-7 Breast | 258 / 11152 (2.3%) | 9181 / 111520 (8.2%) | −144.3 | −141.8 | 0.28 |
| LEO1 SRX1873456 | SEM Blood | 1056 / 11152 (9.5%) | 4089 / 111520 (3.7%) | −144.2 | −141.7 | 2.58 |
| MEAF6 DRX234811 | 293 Kidney | 1192 / 11152 (10.7%) | 4967 / 111520 (4.5%) | −143.4 | −140.9 | 2.40 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1303 / 11152 (11.7%) | 5706 / 111520 (5.1%) | −143.2 | −140.7 | 2.28 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 130 / 11152 (1.2%) | 6799 / 111520 (6.1%) | −143.1 | −140.6 | 0.19 |
| MECOM SRX23677896 | HNT-34 Blood | 1506 / 11152 (13.5%) | 7104 / 111520 (6.4%) | −142.8 | −140.3 | 2.12 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 253 / 11152 (2.3%) | 9044 / 111520 (8.1%) | −142.7 | −140.2 | 0.28 |
| MECOM SRX23677885 | HNT-34 Blood | 1257 / 11152 (11.3%) | 5409 / 111520 (4.9%) | −142.6 | −140.1 | 2.32 |
| MEAF6 DRX300417 | 293 Kidney | 1105 / 11152 (9.9%) | 4446 / 111520 (4.0%) | −141.3 | −138.9 | 2.49 |
| GRHL3 SRX2582162 | NHEK Epidermis | 780 / 11152 (7.0%) | 2508 / 111520 (2.2%) | −140.6 | −138.1 | 3.11 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1275 / 11152 (11.4%) | 5578 / 111520 (5.0%) | −140.1 | −137.7 | 2.29 |
| FOXA1 SRX371481 | MCF-7 Breast | 208 / 11152 (1.9%) | 8177 / 111520 (7.3%) | −140.1 | −137.6 | 0.25 |
| FOXA1 SRX1161173 | MCF-7 Breast | 142 / 11152 (1.3%) | 6935 / 111520 (6.2%) | −139.5 | −137.1 | 0.20 |
| RAC1 SRX10365541 | MCF-7 Breast | 80 / 11152 (0.7%) | 5648 / 111520 (5.1%) | −139.5 | −137.1 | 0.14 |
| FOXA1 SRX371483 | MCF-7 Breast | 227 / 11152 (2.0%) | 8484 / 111520 (7.6%) | −139.1 | −136.7 | 0.27 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1271 / 11152 (11.4%) | 5571 / 111520 (5.0%) | −139.1 | −136.7 | 2.28 |
| MECOM SRX23677884 | HNT-34 Blood | 1230 / 11152 (11.0%) | 5306 / 111520 (4.8%) | −138.7 | −136.3 | 2.32 |
| VGLL1 SRX24602130 | BT-20 Breast | 196 / 11152 (1.8%) | 7908 / 111520 (7.1%) | −138.3 | −135.9 | 0.25 |
| FOXA1 SRX1161175 | MCF-7 Breast | 133 / 11152 (1.2%) | 6710 / 111520 (6.0%) | −137.8 | −135.4 | 0.20 |
| GATA3 SRX190194 | SK-N-SH Neural | 503 / 11152 (4.5%) | 12829 / 111520 (11.5%) | −137.7 | −135.3 | 0.39 |
| ESR1 SRX371469 | MCF-7 Breast | 213 / 11152 (1.9%) | 8185 / 111520 (7.3%) | −137.4 | −135.0 | 0.26 |
| ERG SRX063922 | K-562 Blood | 1120 / 11152 (10.0%) | 4617 / 111520 (4.1%) | −137.0 | −134.6 | 2.43 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 181 / 11152 (1.6%) | 7597 / 111520 (6.8%) | −137.0 | −134.6 | 0.24 |
| JUN SRX17561461 | LPS141 Adipocyte | 285 / 11152 (2.6%) | 9395 / 111520 (8.4%) | −136.6 | −134.2 | 0.30 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 896 / 11152 (8.0%) | 3231 / 111520 (2.9%) | −136.6 | −134.2 | 2.77 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 459 / 11152 (4.1%) | 944 / 111520 (0.8%) | −135.8 | −133.5 | 4.86 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1111 / 11152 (10.0%) | 4593 / 111520 (4.1%) | −135.1 | −132.7 | 2.42 |
| MECOM SRX23677897 | HNT-34 Blood | 1429 / 11152 (12.8%) | 6737 / 111520 (6.0%) | −135.0 | −132.7 | 2.12 |
| AR SRX1067070 | LHSAR Prostate | 531 / 11152 (4.8%) | 13121 / 111520 (11.8%) | −134.4 | −132.0 | 0.40 |
| ESR1 SRX371470 | ZR-75-1 Breast | 184 / 11152 (1.6%) | 7552 / 111520 (6.8%) | −133.7 | −131.4 | 0.24 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 213 / 11152 (1.9%) | 8066 / 111520 (7.2%) | −133.6 | −131.2 | 0.26 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 194 / 11152 (1.7%) | 84 / 111520 (0.1%) | −133.4 | −131.0 | 23.10 |
| STAT5B SRX831881 | CD8+ T cells Blood | 204 / 11152 (1.8%) | 105 / 111520 (0.1%) | −132.7 | −130.4 | 19.43 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 730 / 11152 (6.5%) | 15870 / 111520 (14.2%) | −132.7 | −130.3 | 0.46 |
| YAP1 SRX5718140 | 293 Kidney | 361 / 11152 (3.2%) | 10474 / 111520 (9.4%) | −132.3 | −129.9 | 0.34 |
| ESR1 SRX371476 | MCF-7 Breast | 143 / 11152 (1.3%) | 6730 / 111520 (6.0%) | −131.9 | −129.5 | 0.21 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 177 / 11152 (1.6%) | 7358 / 111520 (6.6%) | −131.4 | −129.1 | 0.24 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 195 / 11152 (1.7%) | 7679 / 111520 (6.9%) | −131.4 | −129.1 | 0.25 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 307 / 11152 (2.8%) | 9578 / 111520 (8.6%) | −131.2 | −128.9 | 0.32 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1163 / 11152 (10.4%) | 5010 / 111520 (4.5%) | −131.1 | −128.7 | 2.32 |
| Epitope tags SRX10549778 | K-562 Blood | 806 / 11152 (7.2%) | 2786 / 111520 (2.5%) | −130.8 | −128.5 | 2.89 |
| ESR1 SRX7624157 | MCF-7 Breast | 573 / 11152 (5.1%) | 13587 / 111520 (12.2%) | −130.6 | −128.2 | 0.42 |
| ESR1 SRX4367193 | MCF-7 Breast | 730 / 11152 (6.5%) | 15783 / 111520 (14.2%) | −130.4 | −128.1 | 0.46 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 177 / 11152 (1.6%) | 7320 / 111520 (6.6%) | −130.2 | −127.9 | 0.24 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 475 / 11152 (4.3%) | 12146 / 111520 (10.9%) | −130.2 | −127.9 | 0.39 |
| ERG SRX063921 | K-562 Blood | 1047 / 11152 (9.4%) | 4274 / 111520 (3.8%) | −130.1 | −127.7 | 2.45 |
| ESR1 SRX20282961 | MCF-7 Breast | 275 / 11152 (2.5%) | 9012 / 111520 (8.1%) | −130.0 | −127.7 | 0.31 |
| ZFX SRX7805372 | 293 Kidney | 1099 / 11152 (9.9%) | 4610 / 111520 (4.1%) | −130.0 | −127.7 | 2.38 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 380 / 11152 (3.4%) | 662 / 111520 (0.6%) | −129.5 | −127.2 | 5.74 |
| BMI1 SRX644729 | 293 Kidney | 195 / 11152 (1.7%) | 95 / 111520 (0.1%) | −129.2 | −126.9 | 20.53 |
| Epitope tags DRX443510 | 293 Kidney | 1018 / 11152 (9.1%) | 4106 / 111520 (3.7%) | −129.1 | −126.8 | 2.48 |
| ESR1 SRX7624156 | MCF-7 Breast | 355 / 11152 (3.2%) | 10270 / 111520 (9.2%) | −129.0 | −126.7 | 0.35 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 177 / 11152 (1.6%) | 7282 / 111520 (6.5%) | −129.0 | −126.7 | 0.24 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 271 / 11152 (2.4%) | 8910 / 111520 (8.0%) | −128.8 | −126.5 | 0.30 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 181 / 11152 (1.6%) | 7349 / 111520 (6.6%) | −128.8 | −126.5 | 0.25 |
| ESR1 SRX371479 | MCF-7 Breast | 197 / 11152 (1.8%) | 7624 / 111520 (6.8%) | −128.4 | −126.1 | 0.26 |
| GATA3 SRX176864 | MCF-7 Breast | 146 / 11152 (1.3%) | 6674 / 111520 (6.0%) | −128.0 | −125.7 | 0.22 |
| FOXA1 SRX1787653 | MCF-7 Breast | 160 / 11152 (1.4%) | 6923 / 111520 (6.2%) | −127.5 | −125.2 | 0.23 |
| FOXA1 SRX11222441 | MCF-7 Breast | 144 / 11152 (1.3%) | 6615 / 111520 (5.9%) | −127.3 | −125.0 | 0.22 |
| JUN SRX4192884 | MCF 10A Breast | 156 / 11152 (1.4%) | 6823 / 111520 (6.1%) | −126.6 | −124.3 | 0.23 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 189 / 11152 (1.7%) | 7418 / 111520 (6.7%) | −126.3 | −124.0 | 0.25 |
| ESR1 SRX371471 | ZR-75-1 Breast | 236 / 11152 (2.1%) | 8235 / 111520 (7.4%) | −126.1 | −123.9 | 0.29 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 356 / 11152 (3.2%) | 10188 / 111520 (9.1%) | −126.1 | −123.8 | 0.35 |
| RORC SRX5359052 | HCC70 Breast | 910 / 11152 (8.2%) | 3480 / 111520 (3.1%) | −126.1 | −123.8 | 2.61 |
| ARID1A SRX5089376 | MCF-7 Breast | 178 / 11152 (1.6%) | 7205 / 111520 (6.5%) | −125.9 | −123.6 | 0.25 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 174 / 11152 (1.6%) | 7133 / 111520 (6.4%) | −125.9 | −123.6 | 0.24 |
| FOXA1 SRX1161174 | MCF-7 Breast | 217 / 11152 (1.9%) | 7888 / 111520 (7.1%) | −125.5 | −123.3 | 0.28 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 204 / 11152 (1.8%) | 7644 / 111520 (6.9%) | −125.1 | −122.8 | 0.27 |
| RAC1 SRX10365543 | MCF-7 Breast | 96 / 11152 (0.9%) | 5591 / 111520 (5.0%) | −124.9 | −122.6 | 0.17 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1300 / 11152 (11.7%) | 6070 / 111520 (5.4%) | −124.6 | −122.3 | 2.14 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 935 / 11152 (8.4%) | 3663 / 111520 (3.3%) | −124.3 | −122.1 | 2.55 |
| JUNB SRX4192882 | MCF 10A Breast | 150 / 11152 (1.3%) | 6643 / 111520 (6.0%) | −124.3 | −122.0 | 0.23 |
| SMARCA2 SRX8119677 | MeT-5A Others | 356 / 11152 (3.2%) | 10120 / 111520 (9.1%) | −124.2 | −121.9 | 0.35 |
| RORC SRX5359053 | HCC70 Breast | 873 / 11152 (7.8%) | 3298 / 111520 (3.0%) | −123.2 | −120.9 | 2.65 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 186 / 11152 (1.7%) | 7256 / 111520 (6.5%) | −122.9 | −120.6 | 0.26 |
| FOXA1 SRX371480 | MCF-7 Breast | 137 / 11152 (1.2%) | 6350 / 111520 (5.7%) | −122.8 | −120.6 | 0.22 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 974 / 11152 (8.7%) | 3938 / 111520 (3.5%) | −122.8 | −120.5 | 2.47 |
| FOXA1 SRX100454 | T-47D Breast | 276 / 11152 (2.5%) | 8789 / 111520 (7.9%) | −122.7 | −120.5 | 0.31 |
| JUNB SRX10119386 | MCF 10A Breast | 180 / 11152 (1.6%) | 7142 / 111520 (6.4%) | −122.6 | −120.4 | 0.25 |
| RBFOX2 SRX4708082 | K-562 Blood | 1614 / 11152 (14.5%) | 8379 / 111520 (7.5%) | −122.0 | −119.8 | 1.93 |
| GATA3 SRX5057632 | MCF-7 Breast | 132 / 11152 (1.2%) | 6226 / 111520 (5.6%) | −121.9 | −119.6 | 0.21 |
| ESR1 SRX20282939 | MCF-7 Breast | 258 / 11152 (2.3%) | 8464 / 111520 (7.6%) | −121.8 | −119.5 | 0.30 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 474 / 11152 (4.3%) | 11805 / 111520 (10.6%) | −121.4 | −119.1 | 0.40 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1309 / 11152 (11.7%) | 6209 / 111520 (5.6%) | −121.2 | −119.0 | 2.11 |
| AR SRX9469988 | LAPC-4 Prostate | 290 / 11152 (2.6%) | 8950 / 111520 (8.0%) | −120.7 | −118.5 | 0.32 |
| YAP1 SRX10119364 | MCF 10A Breast | 166 / 11152 (1.5%) | 6825 / 111520 (6.1%) | −120.5 | −118.3 | 0.24 |
| CXXC1 SRX1424886 | SEM Blood | 991 / 11152 (8.9%) | 4087 / 111520 (3.7%) | −120.4 | −118.2 | 2.42 |
| FOXA1 SRX3931043 | MCF-7 Breast | 217 / 11152 (1.9%) | 7708 / 111520 (6.9%) | −120.0 | −117.7 | 0.28 |
| ESR1 SRX194572 | MCF-7 Breast | 130 / 11152 (1.2%) | 6131 / 111520 (5.5%) | −119.9 | −117.7 | 0.21 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 190 / 11152 (1.7%) | 7234 / 111520 (6.5%) | −119.8 | −117.6 | 0.26 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 758 / 11152 (6.8%) | 15730 / 111520 (14.1%) | −119.7 | −117.5 | 0.48 |
| ESR1 SRX1531791 | MCF-7 Breast | 216 / 11152 (1.9%) | 7683 / 111520 (6.9%) | −119.7 | −117.5 | 0.28 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 477 / 11152 (4.3%) | 1161 / 111520 (1.0%) | −119.6 | −117.4 | 4.11 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 844 / 11152 (7.6%) | 3188 / 111520 (2.9%) | −119.2 | −117.0 | 2.65 |
| JUN SRX883584 | MDA-MB-231 Breast | 352 / 11152 (3.2%) | 9882 / 111520 (8.9%) | −119.1 | −116.9 | 0.36 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 203 / 11152 (1.8%) | 7433 / 111520 (6.7%) | −118.9 | −116.7 | 0.27 |
| FOXA1 SRX11222442 | MCF-7 Breast | 133 / 11152 (1.2%) | 6157 / 111520 (5.5%) | −118.8 | −116.6 | 0.22 |
| ESR1 SRX20282960 | MCF-7 Breast | 263 / 11152 (2.4%) | 8441 / 111520 (7.6%) | −118.7 | −116.5 | 0.31 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 393 / 11152 (3.5%) | 10480 / 111520 (9.4%) | −118.3 | −116.1 | 0.38 |
| ESR1 SRX371468 | MCF-7 Breast | 136 / 11152 (1.2%) | 6180 / 111520 (5.5%) | −117.6 | −115.4 | 0.22 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 146 / 11152 (1.3%) | 6366 / 111520 (5.7%) | −117.6 | −115.4 | 0.23 |
| SMARCA4 SRX5212362 | Mel270 Others | 389 / 11152 (3.5%) | 10381 / 111520 (9.3%) | −117.1 | −115.0 | 0.37 |
| CEBPB SRX150632 | HeLa Uterus | 520 / 11152 (4.7%) | 12309 / 111520 (11.0%) | −116.9 | −114.8 | 0.42 |
| SMARCA4 SRX5212366 | Mel270 Others | 297 / 11152 (2.7%) | 8934 / 111520 (8.0%) | −116.8 | −114.6 | 0.33 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 93 / 11152 (0.8%) | 5293 / 111520 (4.7%) | −116.5 | −114.3 | 0.18 |
| JUNB SRX8488089 | SUM 229PE Breast | 220 / 11152 (2.0%) | 7642 / 111520 (6.9%) | −116.2 | −114.0 | 0.29 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 165 / 11152 (1.5%) | 6670 / 111520 (6.0%) | −116.0 | −113.9 | 0.25 |
| ESR1 SRX176860 | MCF-7 Breast | 389 / 11152 (3.5%) | 10340 / 111520 (9.3%) | −115.9 | −113.8 | 0.38 |
| ESR1 SRX194569 | MCF-7 Breast | 242 / 11152 (2.2%) | 7999 / 111520 (7.2%) | −115.7 | −113.5 | 0.30 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 240 / 11152 (2.2%) | 7950 / 111520 (7.1%) | −115.3 | −113.2 | 0.30 |
| MECOM SRX23677890 | HNT-34 Blood | 1215 / 11152 (10.9%) | 5694 / 111520 (5.1%) | −115.0 | −112.9 | 2.13 |
| JUNB SRX8488073 | SUM 229PE Breast | 433 / 11152 (3.9%) | 10942 / 111520 (9.8%) | −114.4 | −112.3 | 0.40 |
| STAT1 SRX23678708 | K-562 Blood | 1039 / 11152 (9.3%) | 4518 / 111520 (4.1%) | −114.3 | −112.1 | 2.30 |
| FOXA1 SRX11222437 | MCF-7 Breast | 154 / 11152 (1.4%) | 6411 / 111520 (5.7%) | −114.2 | −112.1 | 0.24 |
| ESR1 SRX176861 | MCF-7 Breast | 399 / 11152 (3.6%) | 10421 / 111520 (9.3%) | −114.1 | −111.9 | 0.38 |
| ZFX SRX7805370 | 293 Kidney | 785 / 11152 (7.0%) | 2910 / 111520 (2.6%) | −114.0 | −111.9 | 2.70 |
| FOXA1 SRX1787655 | MCF-7 Breast | 100 / 11152 (0.9%) | 5363 / 111520 (4.8%) | −113.8 | −111.7 | 0.19 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 378 / 11152 (3.4%) | 763 / 111520 (0.7%) | −113.7 | −111.5 | 4.95 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 743 / 11152 (6.7%) | 2665 / 111520 (2.4%) | −113.6 | −111.5 | 2.79 |
| ESR1 SRX371467 | MCF-7 Breast | 248 / 11152 (2.2%) | 8029 / 111520 (7.2%) | −113.6 | −111.4 | 0.31 |
| AR SRX1067067 | LHSAR Prostate | 396 / 11152 (3.6%) | 10358 / 111520 (9.3%) | −113.5 | −111.4 | 0.38 |
| MECOM SRX23677891 | HNT-34 Blood | 1204 / 11152 (10.8%) | 5651 / 111520 (5.1%) | −113.5 | −111.3 | 2.13 |
| SMARCA4 SRX5212357 | Mel270 Others | 328 / 11152 (2.9%) | 9311 / 111520 (8.3%) | −113.4 | −111.3 | 0.35 |
| FOXA1 SRX3923514 | MCF-7 Breast | 230 / 11152 (2.1%) | 7724 / 111520 (6.9%) | −113.4 | −111.3 | 0.30 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 173 / 11152 (1.6%) | 6731 / 111520 (6.0%) | −113.3 | −111.2 | 0.26 |
| KMT2A SRX2281249 | SEM Blood | 1298 / 11152 (11.6%) | 6316 / 111520 (5.7%) | −113.2 | −111.1 | 2.06 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 847 / 11152 (7.6%) | 3303 / 111520 (3.0%) | −113.1 | −110.9 | 2.56 |
| JADE3 DRX300415 | 293 Kidney | 1020 / 11152 (9.1%) | 4420 / 111520 (4.0%) | −112.8 | −110.7 | 2.31 |
| Epitope tags SRX10549777 | K-562 Blood | 1630 / 11152 (14.6%) | 8748 / 111520 (7.8%) | −112.8 | −110.6 | 1.86 |
| ESR1 SRX10365536 | MCF-7 Breast | 112 / 11152 (1.0%) | 5568 / 111520 (5.0%) | −112.7 | −110.6 | 0.20 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1065 / 11152 (9.5%) | 4725 / 111520 (4.2%) | −112.5 | −110.4 | 2.25 |
| ESR1 SRX371477 | MCF-7 Breast | 103 / 11152 (0.9%) | 5382 / 111520 (4.8%) | −112.3 | −110.2 | 0.19 |
| ESR1 SRX371475 | BT-474 Breast | 106 / 11152 (1.0%) | 5433 / 111520 (4.9%) | −112.2 | −110.0 | 0.20 |
| TET2 SRX1427029 | 293 Kidney | 876 / 11152 (7.9%) | 3505 / 111520 (3.1%) | −112.0 | −109.9 | 2.50 |
| INTS3 SRX3640569 | HeLa Uterus | 856 / 11152 (7.7%) | 3382 / 111520 (3.0%) | −111.9 | −109.8 | 2.53 |
| AR SRX1067066 | LHSAR Prostate | 494 / 11152 (4.4%) | 11742 / 111520 (10.5%) | −111.8 | −109.7 | 0.42 |
| ARID1A SRX5089379 | MCF-7 Breast | 231 / 11152 (2.1%) | 7667 / 111520 (6.9%) | −111.3 | −109.2 | 0.30 |
| FOXA1 SRX3931055 | MCF-7 Breast | 187 / 11152 (1.7%) | 6915 / 111520 (6.2%) | −111.3 | −109.1 | 0.27 |
| FOXA1 SRX3931054 | MCF-7 Breast | 214 / 11152 (1.9%) | 7380 / 111520 (6.6%) | −111.2 | −109.1 | 0.29 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 600 / 11152 (5.4%) | 1883 / 111520 (1.7%) | −111.1 | −109.0 | 3.19 |
| FOS SRX3322636 | MCF-7 Breast | 139 / 11152 (1.2%) | 6037 / 111520 (5.4%) | −111.0 | −108.8 | 0.23 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 215 / 11152 (1.9%) | 7387 / 111520 (6.6%) | −110.9 | −108.8 | 0.29 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1073 / 11152 (9.6%) | 4814 / 111520 (4.3%) | −110.9 | −108.8 | 2.23 |
| EP300 SRX150579 | HeLa Uterus | 137 / 11152 (1.2%) | 5988 / 111520 (5.4%) | −110.7 | −108.6 | 0.23 |
| GRHL3 SRX2582161 | NHEK Epidermis | 615 / 11152 (5.5%) | 1974 / 111520 (1.8%) | −110.5 | −108.4 | 3.12 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 309 / 11152 (2.8%) | 8892 / 111520 (8.0%) | −110.0 | −107.9 | 0.35 |
| CHD6 SRX17709200 | C4-2 Prostate | 1048 / 11152 (9.4%) | 4666 / 111520 (4.2%) | −109.9 | −107.8 | 2.25 |
| EP300 SRX176885 | MCF-7 Breast | 112 / 11152 (1.0%) | 5478 / 111520 (4.9%) | −109.6 | −107.5 | 0.20 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 206 / 11152 (1.8%) | 7190 / 111520 (6.4%) | −109.6 | −107.5 | 0.29 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 135 / 11152 (1.2%) | 5923 / 111520 (5.3%) | −109.6 | −107.5 | 0.23 |
| FOXA1 SRX1787652 | MCF-7 Breast | 132 / 11152 (1.2%) | 5863 / 111520 (5.3%) | −109.6 | −107.5 | 0.23 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 563 / 11152 (5.0%) | 12630 / 111520 (11.3%) | −109.5 | −107.4 | 0.45 |
| NABP2 SRX9523535 | HT-1080 Bone | 920 / 11152 (8.2%) | 3843 / 111520 (3.4%) | −108.8 | −106.7 | 2.39 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 300 / 11152 (2.7%) | 8709 / 111520 (7.8%) | −108.8 | −106.7 | 0.34 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 456 / 11152 (4.1%) | 11072 / 111520 (9.9%) | −108.8 | −106.7 | 0.41 |
| JUNB SRX10119383 | MCF 10A Breast | 148 / 11152 (1.3%) | 6133 / 111520 (5.5%) | −108.6 | −106.5 | 0.24 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 462 / 11152 (4.1%) | 11148 / 111520 (10.0%) | −108.5 | −106.5 | 0.41 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1013 / 11152 (9.1%) | 4462 / 111520 (4.0%) | −108.3 | −106.2 | 2.27 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1500 / 11152 (13.5%) | 7905 / 111520 (7.1%) | −108.1 | −106.1 | 1.90 |
| NFYB SRX16608147 | HeLa Uterus | 187 / 11152 (1.7%) | 132 / 111520 (0.1%) | −108.1 | −106.0 | 14.17 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 168 / 11152 (1.5%) | 6481 / 111520 (5.8%) | −108.1 | −106.0 | 0.26 |
| KMT2A SRX2323891 | 293 Kidney | 666 / 11152 (6.0%) | 2297 / 111520 (2.1%) | −107.9 | −105.9 | 2.90 |
| SSRP1 SRX3436567 | HT-1080 Bone | 273 / 11152 (2.4%) | 390 / 111520 (0.3%) | −107.8 | −105.7 | 7.00 |
| TET2 SRX2014505 | Jurkat Blood | 1734 / 11152 (15.5%) | 9683 / 111520 (8.7%) | −107.7 | −105.6 | 1.79 |
| ESR1 SRX10365532 | MCF-7 Breast | 119 / 11152 (1.1%) | 5560 / 111520 (5.0%) | −107.7 | −105.6 | 0.21 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 213 / 11152 (1.9%) | 7246 / 111520 (6.5%) | −107.6 | −105.6 | 0.29 |
| FOSL2 SRX190296 | SK-N-SH Neural | 309 / 11152 (2.8%) | 8803 / 111520 (7.9%) | −107.4 | −105.4 | 0.35 |
| FOXA1 SRX5323843 | MCF-7 Breast | 108 / 11152 (1.0%) | 5335 / 111520 (4.8%) | −107.4 | −105.3 | 0.20 |
| TLE3 SRX4815192 | MCF-7 Breast | 217 / 11152 (1.9%) | 7307 / 111520 (6.6%) | −107.4 | −105.3 | 0.30 |
| PGR SRX1012655 | MCF-7 Breast | 144 / 11152 (1.3%) | 6018 / 111520 (5.4%) | −107.2 | −105.2 | 0.24 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 545 / 11152 (4.9%) | 1633 / 111520 (1.5%) | −107.2 | −105.1 | 3.34 |
| TEAD1 SRX3401272 | MCF-7 Breast | 174 / 11152 (1.6%) | 6555 / 111520 (5.9%) | −107.2 | −105.1 | 0.27 |
| ESR1 SRX371474 | BT-474 Breast | 99 / 11152 (0.9%) | 5152 / 111520 (4.6%) | −107.2 | −105.1 | 0.19 |
| MEN1 SRX11712604 | K-562 Blood | 942 / 11152 (8.4%) | 4020 / 111520 (3.6%) | −107.1 | −105.0 | 2.34 |
| ESR1 SRX20282972 | MCF-7 Breast | 275 / 11152 (2.5%) | 8244 / 111520 (7.4%) | −106.9 | −104.8 | 0.33 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 217 / 11152 (1.9%) | 7284 / 111520 (6.5%) | −106.7 | −104.6 | 0.30 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 328 / 11152 (2.9%) | 9066 / 111520 (8.1%) | −106.6 | −104.5 | 0.36 |
| JUNB SRX8488074 | SUM 229PE Breast | 316 / 11152 (2.8%) | 8880 / 111520 (8.0%) | −106.5 | −104.4 | 0.36 |
| WWTR1 SRX10119367 | MCF 10A Breast | 274 / 11152 (2.5%) | 8212 / 111520 (7.4%) | −106.5 | −104.4 | 0.33 |
| CDK9 SRX7366783 | MCF-7 Breast | 174 / 11152 (1.6%) | 107 / 111520 (0.1%) | −106.3 | −104.2 | 16.26 |
| CDK9 SRX7366781 | MCF-7 Breast | 167 / 11152 (1.5%) | 92 / 111520 (0.1%) | −106.2 | −104.2 | 18.15 |
| JUNB SRX10119384 | MCF 10A Breast | 129 / 11152 (1.2%) | 5703 / 111520 (5.1%) | −106.2 | −104.1 | 0.23 |
| WWTR1 SRX10119378 | MCF 10A Breast | 258 / 11152 (2.3%) | 7940 / 111520 (7.1%) | −106.1 | −104.1 | 0.32 |
| JUND SRX190357 | SK-N-SH Neural | 296 / 11152 (2.7%) | 8550 / 111520 (7.7%) | −106.1 | −104.1 | 0.35 |
| FOXA1 SRX100506 | Hep G2 Liver | 317 / 11152 (2.8%) | 8856 / 111520 (7.9%) | −105.4 | −103.4 | 0.36 |
| JUND SRX150408 | HeLa Uterus | 201 / 11152 (1.8%) | 6968 / 111520 (6.2%) | −105.3 | −103.3 | 0.29 |
| ESR1 SRX20282954 | MCF-7 Breast | 273 / 11152 (2.4%) | 8157 / 111520 (7.3%) | −105.2 | −103.2 | 0.33 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 1027 / 11152 (9.2%) | 4622 / 111520 (4.1%) | −105.1 | −103.1 | 2.22 |
| MethylCap SRX014767 | NB-4 Blood | 1147 / 11152 (10.3%) | 5447 / 111520 (4.9%) | −105.0 | −102.9 | 2.11 |
| SMARCA4 SRX5212371 | Mel270 Others | 343 / 11152 (3.1%) | 9235 / 111520 (8.3%) | −104.8 | −102.8 | 0.37 |
| ESR1 SRX2943591 | MCF-7 Breast | 165 / 11152 (1.5%) | 6321 / 111520 (5.7%) | −104.7 | −102.7 | 0.26 |
| Epitope tags SRX7276677 | 293 Kidney | 1745 / 11152 (15.6%) | 9861 / 111520 (8.8%) | −104.6 | −102.6 | 1.77 |
| ESR1 SRX2881000 | MCF-7 Breast | 212 / 11152 (1.9%) | 7128 / 111520 (6.4%) | −104.5 | −102.5 | 0.30 |
| CBFB SRX265218 | ME-1 Blood | 972 / 11152 (8.7%) | 4272 / 111520 (3.8%) | −104.3 | −102.3 | 2.28 |
| FOXA1 SRX1447317 | MCF-7 Breast | 146 / 11152 (1.3%) | 5959 / 111520 (5.3%) | −104.1 | −102.1 | 0.25 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 808 / 11152 (7.2%) | 3215 / 111520 (2.9%) | −104.1 | −102.1 | 2.51 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 251 / 11152 (2.3%) | 7756 / 111520 (7.0%) | −104.0 | −101.9 | 0.32 |
| ARID1A SRX5089385 | MCF-7 Breast | 177 / 11152 (1.6%) | 6509 / 111520 (5.8%) | −104.0 | −101.9 | 0.27 |
| EP300 SRX1012648 | MCF-7 Breast | 104 / 11152 (0.9%) | 5158 / 111520 (4.6%) | −104.0 | −101.9 | 0.20 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 188 / 11152 (1.7%) | 6692 / 111520 (6.0%) | −103.8 | −101.8 | 0.28 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 774 / 11152 (6.9%) | 15270 / 111520 (13.7%) | −103.7 | −101.7 | 0.51 |
| ESR1 SRX1012632 | MCF-7 Breast | 111 / 11152 (1.0%) | 5282 / 111520 (4.7%) | −103.5 | −101.5 | 0.21 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1105 / 11152 (9.9%) | 5191 / 111520 (4.7%) | −103.4 | −101.4 | 2.13 |
| FOXA1 SRX1161203 | T-47D Breast | 166 / 11152 (1.5%) | 6296 / 111520 (5.6%) | −103.3 | −101.3 | 0.26 |
| SREBF2 SRX5359049 | HCC70 Breast | 788 / 11152 (7.1%) | 3105 / 111520 (2.8%) | −103.2 | −101.1 | 2.54 |
| PRRX1 SRX15235713 | Hs 578T Breast | 296 / 11152 (2.7%) | 8446 / 111520 (7.6%) | −103.1 | −101.1 | 0.35 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 159 / 11152 (1.4%) | 6158 / 111520 (5.5%) | −103.0 | −101.0 | 0.26 |
| KAT7 DRX234808 | 293 Kidney | 527 / 11152 (4.7%) | 1587 / 111520 (1.4%) | −102.9 | −100.9 | 3.32 |
| RELA SRX2207672 | HUVEC Cardiovascular | 942 / 11152 (8.4%) | 17420 / 111520 (15.6%) | −102.9 | −100.9 | 0.54 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 602 / 11152 (5.4%) | 12893 / 111520 (11.6%) | −102.5 | −100.5 | 0.47 |
| FOXA1 SRX3923517 | MCF-7 Breast | 167 / 11152 (1.5%) | 6281 / 111520 (5.6%) | −102.4 | −100.4 | 0.27 |
| CHD6 SRX17709201 | C4-2 Prostate | 996 / 11152 (8.9%) | 4469 / 111520 (4.0%) | −102.4 | −100.4 | 2.23 |
| ING2 SRX286201 | RKO Digestive tract | 922 / 11152 (8.3%) | 3980 / 111520 (3.6%) | −102.3 | −100.3 | 2.32 |
| BRD2 SRX8090652 | Synoviocytes Others | 790 / 11152 (7.1%) | 3136 / 111520 (2.8%) | −102.1 | −100.1 | 2.52 |
| GATA3 SRX6712581 | MCF-7 Breast | 200 / 11152 (1.8%) | 6837 / 111520 (6.1%) | −101.9 | −99.9 | 0.29 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 198 / 11152 (1.8%) | 6801 / 111520 (6.1%) | −101.8 | −99.8 | 0.29 |
| RELA SRX2207673 | HUVEC Cardiovascular | 885 / 11152 (7.9%) | 16640 / 111520 (14.9%) | −101.8 | −99.8 | 0.53 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 168 / 11152 (1.5%) | 6279 / 111520 (5.6%) | −101.8 | −99.8 | 0.27 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 112 / 11152 (1.0%) | 5248 / 111520 (4.7%) | −101.7 | −99.7 | 0.21 |
| TCF12 SRX190356 | SK-N-SH Neural | 677 / 11152 (6.1%) | 13885 / 111520 (12.5%) | −101.7 | −99.7 | 0.49 |
| FOXA1 SRX028635 | MCF-7 Breast | 114 / 11152 (1.0%) | 5285 / 111520 (4.7%) | −101.7 | −99.7 | 0.22 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 480 / 11152 (4.3%) | 11145 / 111520 (10.0%) | −101.6 | −99.7 | 0.43 |
| NR2F2 SRX190293 | MCF-7 Breast | 268 / 11152 (2.4%) | 7945 / 111520 (7.1%) | −101.5 | −99.5 | 0.34 |
| FOXA2 SRX3230382 | Hep G2 Liver | 332 / 11152 (3.0%) | 8945 / 111520 (8.0%) | −101.4 | −99.4 | 0.37 |
| FOXA1 SRX5323829 | T-47D Breast | 127 / 11152 (1.1%) | 5516 / 111520 (4.9%) | −101.2 | −99.2 | 0.23 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 54 / 11152 (0.5%) | 4017 / 111520 (3.6%) | −101.0 | −99.0 | 0.13 |
| FOXA1 SRX5203303 | MCF-7 Breast | 70 / 11152 (0.6%) | 4373 / 111520 (3.9%) | −101.0 | −99.0 | 0.16 |
| FOXL2 SRX6957431 | KGN Gonad | 565 / 11152 (5.1%) | 12315 / 111520 (11.0%) | −100.9 | −98.9 | 0.46 |
| FOXA2 SRX100448 | Hep G2 Liver | 269 / 11152 (2.4%) | 7931 / 111520 (7.1%) | −100.6 | −98.6 | 0.34 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 138 / 11152 (1.2%) | 49 / 111520 (0.0%) | −100.5 | −98.5 | 28.16 |
| ESR1 SRX20282946 | MCF-7 Breast | 145 / 11152 (1.3%) | 5825 / 111520 (5.2%) | −100.5 | −98.5 | 0.25 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 578 / 11152 (5.2%) | 1899 / 111520 (1.7%) | −100.3 | −98.3 | 3.04 |
| ZNF711 SRX7805363 | 293 Kidney | 1003 / 11152 (9.0%) | 4561 / 111520 (4.1%) | −100.3 | −98.3 | 2.20 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 715 / 11152 (6.4%) | 14313 / 111520 (12.8%) | −99.8 | −97.8 | 0.50 |
| ZNF711 SRX7805362 | 293 Kidney | 957 / 11152 (8.6%) | 4265 / 111520 (3.8%) | −99.6 | −97.7 | 2.24 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 485 / 11152 (4.3%) | 1404 / 111520 (1.3%) | −99.6 | −97.6 | 3.45 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 502 / 11152 (4.5%) | 1494 / 111520 (1.3%) | −99.5 | −97.5 | 3.36 |
| Epitope tags SRX2867680 | 293 Kidney | 1338 / 11152 (12.0%) | 6949 / 111520 (6.2%) | −99.4 | −97.5 | 1.93 |
| STAT1 SRX23678707 | K-562 Blood | 938 / 11152 (8.4%) | 4147 / 111520 (3.7%) | −99.2 | −97.2 | 2.26 |
| FOXA1 SRX3923516 | MCF-7 Breast | 177 / 11152 (1.6%) | 6356 / 111520 (5.7%) | −99.2 | −97.2 | 0.28 |
| MYOCD SRX5598318 | A549 Lung | 1114 / 11152 (10.0%) | 5350 / 111520 (4.8%) | −99.2 | −97.2 | 2.08 |
| FOXA1 SRX11222438 | MCF-7 Breast | 126 / 11152 (1.1%) | 5436 / 111520 (4.9%) | −99.1 | −97.2 | 0.23 |
| FOXA1 SRX1161205 | T-47D Breast | 121 / 11152 (1.1%) | 5322 / 111520 (4.8%) | −98.5 | −96.5 | 0.23 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 231 / 11152 (2.1%) | 7240 / 111520 (6.5%) | −98.3 | −96.3 | 0.32 |
| FOXA1 SRX3931033 | MCF-7 Breast | 152 / 11152 (1.4%) | 5885 / 111520 (5.3%) | −98.2 | −96.3 | 0.26 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 593 / 11152 (5.3%) | 12594 / 111520 (11.3%) | −98.2 | −96.2 | 0.47 |
| NR3C1 SRX17639412 | A549 Lung | 279 / 11152 (2.5%) | 8002 / 111520 (7.2%) | −98.1 | −96.2 | 0.35 |
| FOXA1 SRX028634 | MCF-7 Breast | 120 / 11152 (1.1%) | 5292 / 111520 (4.7%) | −98.1 | −96.2 | 0.23 |
| EP300 SRX1012644 | MCF-7 Breast | 104 / 11152 (0.9%) | 4984 / 111520 (4.5%) | −98.1 | −96.1 | 0.21 |
| FOSL2 SRX190204 | A549 Lung | 242 / 11152 (2.2%) | 7405 / 111520 (6.6%) | −98.0 | −96.1 | 0.33 |
| FOXA1 SRX1787651 | MCF-7 Breast | 137 / 11152 (1.2%) | 5607 / 111520 (5.0%) | −98.0 | −96.0 | 0.24 |
| NKX2-1 SRX2164786 | A549 Lung | 421 / 11152 (3.8%) | 10146 / 111520 (9.1%) | −97.9 | −95.9 | 0.41 |
| FOXA1 SRX219284 | LNCAP Prostate | 335 / 11152 (3.0%) | 8863 / 111520 (7.9%) | −97.9 | −95.9 | 0.38 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 629 / 11152 (5.6%) | 2227 / 111520 (2.0%) | −97.8 | −95.9 | 2.82 |
| FOXA1 SRX5203294 | MCF-7 Breast | 60 / 11152 (0.5%) | 4064 / 111520 (3.6%) | −97.7 | −95.8 | 0.15 |
| SS18 SRX3468047 | Fibroblasts Others | 631 / 11152 (5.7%) | 13092 / 111520 (11.7%) | −97.7 | −95.8 | 0.48 |
| FOS SRX070879 | HUVEC Cardiovascular | 266 / 11152 (2.4%) | 7779 / 111520 (7.0%) | −97.7 | −95.7 | 0.34 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 104 / 11152 (0.9%) | 4970 / 111520 (4.5%) | −97.6 | −95.7 | 0.21 |
| FOXA1 SRX1787654 | MCF-7 Breast | 84 / 11152 (0.8%) | 4567 / 111520 (4.1%) | −97.5 | −95.5 | 0.18 |
| STAT3 SRX150630 | MCF 10A Breast | 230 / 11152 (2.1%) | 7189 / 111520 (6.4%) | −97.4 | −95.4 | 0.32 |
| RELA SRX5938177 | FaDu Others | 229 / 11152 (2.1%) | 7171 / 111520 (6.4%) | −97.2 | −95.3 | 0.32 |
| ESR1 SRX10365533 | MCF-7 Breast | 114 / 11152 (1.0%) | 5148 / 111520 (4.6%) | −97.1 | −95.2 | 0.22 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 441 / 11152 (4.0%) | 10404 / 111520 (9.3%) | −97.0 | −95.1 | 0.42 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1195 / 11152 (10.7%) | 5976 / 111520 (5.4%) | −97.0 | −95.1 | 2.00 |
| FOXA1 SRX5323845 | MCF-7 Breast | 82 / 11152 (0.7%) | 4510 / 111520 (4.0%) | −97.0 | −95.0 | 0.18 |
| FOXA1 SRX3923518 | MCF-7 Breast | 172 / 11152 (1.5%) | 6196 / 111520 (5.6%) | −97.0 | −95.0 | 0.28 |
| EP300 SRX1012643 | MCF-7 Breast | 81 / 11152 (0.7%) | 4490 / 111520 (4.0%) | −96.9 | −95.0 | 0.18 |
| GATA3 SRX5457550 | MCF-7 Breast | 294 / 11152 (2.6%) | 8191 / 111520 (7.3%) | −96.8 | −94.9 | 0.36 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 164 / 11152 (1.5%) | 6049 / 111520 (5.4%) | −96.7 | −94.8 | 0.27 |
| PHF6 SRX11508321 | G-401 Kidney | 991 / 11152 (8.9%) | 4558 / 111520 (4.1%) | −96.6 | −94.7 | 2.17 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 261 / 11152 (2.3%) | 7665 / 111520 (6.9%) | −96.6 | −94.7 | 0.34 |
| STAT3 SRX150479 | MCF 10A Breast | 233 / 11152 (2.1%) | 7208 / 111520 (6.5%) | −96.5 | −94.6 | 0.32 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 976 / 11152 (8.8%) | 4462 / 111520 (4.0%) | −96.5 | −94.5 | 2.19 |
| FOXA1 SRX15430999 | T-47D Breast | 281 / 11152 (2.5%) | 7973 / 111520 (7.1%) | −96.4 | −94.5 | 0.35 |
| FOXA1 SRX5203307 | MCF-7 Breast | 64 / 11152 (0.6%) | 4116 / 111520 (3.7%) | −96.4 | −94.4 | 0.16 |
| ARID1A SRX5089388 | MCF-7 Breast | 126 / 11152 (1.1%) | 5346 / 111520 (4.8%) | −96.1 | −94.2 | 0.24 |
| ESR1 SRX10365535 | MCF-7 Breast | 213 / 11152 (1.9%) | 6859 / 111520 (6.2%) | −95.9 | −94.0 | 0.31 |
| ARID1A SRX5089391 | MCF-7 Breast | 139 / 11152 (1.2%) | 5574 / 111520 (5.0%) | −95.8 | −93.9 | 0.25 |
| FOXA1 SRX1961157 | T-47D Breast | 275 / 11152 (2.5%) | 7858 / 111520 (7.0%) | −95.7 | −93.8 | 0.35 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 153 / 11152 (1.4%) | 5821 / 111520 (5.2%) | −95.7 | −93.8 | 0.26 |
| NR3C1 SRX19024866 | MCF-7 Breast | 79 / 11152 (0.7%) | 4411 / 111520 (4.0%) | −95.7 | −93.7 | 0.18 |
| ESR1 SRX330070 | MCF-7 Breast | 129 / 11152 (1.2%) | 5382 / 111520 (4.8%) | −95.4 | −93.5 | 0.24 |
| ESR1 SRX20282973 | MCF-7 Breast | 321 / 11152 (2.9%) | 8558 / 111520 (7.7%) | −95.4 | −93.5 | 0.38 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 218 / 11152 (2.0%) | 6926 / 111520 (6.2%) | −95.4 | −93.4 | 0.31 |
| EP300 ERX626821 | U-937 Blood | 783 / 11152 (7.0%) | 3209 / 111520 (2.9%) | −95.3 | −93.4 | 2.44 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 141 / 11152 (1.3%) | 65 / 111520 (0.1%) | −95.3 | −93.4 | 21.69 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 835 / 11152 (7.5%) | 3548 / 111520 (3.2%) | −95.3 | −93.3 | 2.35 |
| CDK9 SRX20230574 | Ishikawa Uterus | 972 / 11152 (8.7%) | 4459 / 111520 (4.0%) | −95.2 | −93.3 | 2.18 |
| ESR1 SRX1012630 | MCF-7 Breast | 91 / 11152 (0.8%) | 4645 / 111520 (4.2%) | −95.2 | −93.3 | 0.20 |
| DAXX SRX1021630 | PC-3 Prostate | 255 / 11152 (2.3%) | 7512 / 111520 (6.7%) | −95.0 | −93.1 | 0.34 |
| STAT3 SRX2020842 | HCC70 Breast | 464 / 11152 (4.2%) | 10654 / 111520 (9.6%) | −95.0 | −93.1 | 0.44 |
| ESR1 SRX1531796 | MCF-7 Breast | 132 / 11152 (1.2%) | 5418 / 111520 (4.9%) | −94.9 | −93.0 | 0.24 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 298 / 11152 (2.7%) | 8186 / 111520 (7.3%) | −94.8 | −92.9 | 0.36 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 138 / 11152 (1.2%) | 5527 / 111520 (5.0%) | −94.8 | −92.9 | 0.25 |
| ESR1 SRX20282940 | MCF-7 Breast | 291 / 11152 (2.6%) | 8066 / 111520 (7.2%) | −94.5 | −92.6 | 0.36 |
| FOXA1 SRX3931056 | MCF-7 Breast | 144 / 11152 (1.3%) | 5622 / 111520 (5.0%) | −94.5 | −92.6 | 0.26 |
| MethylCap SRX014766 | NB-4 Blood | 1014 / 11152 (9.1%) | 4767 / 111520 (4.3%) | −94.4 | −92.5 | 2.13 |
| ESR1 SRX3123829 | MCF-7 Breast | 148 / 11152 (1.3%) | 5690 / 111520 (5.1%) | −94.4 | −92.5 | 0.26 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 441 / 11152 (4.0%) | 10298 / 111520 (9.2%) | −94.3 | −92.4 | 0.43 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 203 / 11152 (1.8%) | 6638 / 111520 (6.0%) | −94.3 | −92.4 | 0.31 |
| ESR1 SRX2912055 | MCF-7 Breast | 92 / 11152 (0.8%) | 4637 / 111520 (4.2%) | −94.3 | −92.4 | 0.20 |
| VGLL1 SRX18013277 | FULVR Breast | 104 / 11152 (0.9%) | 4873 / 111520 (4.4%) | −94.3 | −92.4 | 0.21 |
| ESR1 SRX330069 | MCF-7 Breast | 158 / 11152 (1.4%) | 5860 / 111520 (5.3%) | −94.1 | −92.2 | 0.27 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 579 / 11152 (5.2%) | 12228 / 111520 (11.0%) | −94.1 | −92.2 | 0.47 |
| ESR1 SRX1012633 | MCF-7 Breast | 129 / 11152 (1.2%) | 5339 / 111520 (4.8%) | −94.1 | −92.2 | 0.24 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 254 / 11152 (2.3%) | 7466 / 111520 (6.7%) | −94.1 | −92.2 | 0.34 |
| FOXA1 SRX1961158 | T-47D Breast | 257 / 11152 (2.3%) | 7511 / 111520 (6.7%) | −94.1 | −92.2 | 0.34 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 186 / 11152 (1.7%) | 6344 / 111520 (5.7%) | −94.0 | −92.1 | 0.29 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1069 / 11152 (9.6%) | 5162 / 111520 (4.6%) | −93.7 | −91.8 | 2.07 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 90 / 11152 (0.8%) | 4573 / 111520 (4.1%) | −93.5 | −91.6 | 0.20 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 379 / 11152 (3.4%) | 9359 / 111520 (8.4%) | −93.4 | −91.5 | 0.40 |
| ESR1 SRX1012629 | MCF-7 Breast | 164 / 11152 (1.5%) | 5943 / 111520 (5.3%) | −93.4 | −91.5 | 0.28 |
| ESR1 SRX2943589 | MCF-7 Breast | 129 / 11152 (1.2%) | 5316 / 111520 (4.8%) | −93.4 | −91.5 | 0.24 |
| NR3C1 SRX10977372 | A549 Lung | 138 / 11152 (1.2%) | 5478 / 111520 (4.9%) | −93.4 | −91.5 | 0.25 |
| CEBPB SRX190345 | MCF-7 Breast | 194 / 11152 (1.7%) | 6453 / 111520 (5.8%) | −93.3 | −91.4 | 0.30 |
| RNF2 SRX18954719 | SCC-25 Others | 355 / 11152 (3.2%) | 8996 / 111520 (8.1%) | −93.2 | −91.3 | 0.39 |
| FOXA1 SRX5323830 | T-47D Breast | 148 / 11152 (1.3%) | 5655 / 111520 (5.1%) | −93.2 | −91.3 | 0.26 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 172 / 11152 (1.5%) | 6073 / 111520 (5.4%) | −93.1 | −91.2 | 0.28 |
| AFF1 SRX2281250 | SEM Blood | 627 / 11152 (5.6%) | 2287 / 111520 (2.1%) | −92.9 | −91.0 | 2.74 |
| LARP7 SRX2198835 | HeLa Uterus | 1350 / 11152 (12.1%) | 7216 / 111520 (6.5%) | −92.9 | −91.0 | 1.87 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 217 / 11152 (1.9%) | 6818 / 111520 (6.1%) | −92.8 | −90.9 | 0.32 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 170 / 11152 (1.5%) | 6027 / 111520 (5.4%) | −92.7 | −90.8 | 0.28 |
| PBX3 SRX190343 | SK-N-SH Neural | 546 / 11152 (4.9%) | 11713 / 111520 (10.5%) | −92.7 | −90.8 | 0.47 |
| FOXA1 SRX6878603 | LNCAP Prostate | 281 / 11152 (2.5%) | 7843 / 111520 (7.0%) | −92.7 | −90.8 | 0.36 |
| EP300 SRX2671813 | Fibroblasts Others | 216 / 11152 (1.9%) | 6801 / 111520 (6.1%) | −92.6 | −90.8 | 0.32 |
| KDM5A SRX23740431 | SUM 149PT Breast | 942 / 11152 (8.4%) | 4314 / 111520 (3.9%) | −92.6 | −90.7 | 2.18 |
| RBFOX2 SRX3322781 | K-562 Blood | 1286 / 11152 (11.5%) | 6751 / 111520 (6.1%) | −92.5 | −90.6 | 1.90 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 212 / 11152 (1.9%) | 6726 / 111520 (6.0%) | −92.4 | −90.6 | 0.32 |
| ZEB1 SRX13298925 | MCF-7 Breast | 158 / 11152 (1.4%) | 5807 / 111520 (5.2%) | −92.4 | −90.5 | 0.27 |
| ESR1 SRX20282953 | MCF-7 Breast | 216 / 11152 (1.9%) | 6790 / 111520 (6.1%) | −92.4 | −90.5 | 0.32 |
| GATAD2A SRX2636506 | Hep G2 Liver | 338 / 11152 (3.0%) | 8706 / 111520 (7.8%) | −92.3 | −90.5 | 0.39 |
| ESR1 SRX2881002 | MCF-7 Breast | 257 / 11152 (2.3%) | 7451 / 111520 (6.7%) | −92.3 | −90.4 | 0.34 |
| EP300 SRX176883 | MCF-7 Breast | 117 / 11152 (1.0%) | 5056 / 111520 (4.5%) | −92.2 | −90.3 | 0.23 |
| ARID1A SRX5679787 | 12Z Others | 95 / 11152 (0.9%) | 4631 / 111520 (4.2%) | −92.1 | −90.3 | 0.21 |
| ARID1A SRX5089382 | MCF-7 Breast | 188 / 11152 (1.7%) | 6313 / 111520 (5.7%) | −92.1 | −90.2 | 0.30 |
| Epitope tags SRX2255894 | 293 Kidney | 875 / 11152 (7.8%) | 3878 / 111520 (3.5%) | −91.9 | −90.0 | 2.26 |
| Epitope tags SRX8030771 | 293 Kidney | 1036 / 11152 (9.3%) | 4978 / 111520 (4.5%) | −91.8 | −90.0 | 2.08 |
| FOXA1 SRX3931032 | MCF-7 Breast | 147 / 11152 (1.3%) | 5591 / 111520 (5.0%) | −91.8 | −89.9 | 0.26 |
| JUNB SRX10119385 | MCF 10A Breast | 112 / 11152 (1.0%) | 4945 / 111520 (4.4%) | −91.6 | −89.7 | 0.23 |
| EP300 SRX717859 | HeLa Uterus | 130 / 11152 (1.2%) | 5279 / 111520 (4.7%) | −91.5 | −89.6 | 0.25 |
| ESR1 SRX20282955 | MCF-7 Breast | 288 / 11152 (2.6%) | 7903 / 111520 (7.1%) | −91.4 | −89.5 | 0.36 |
| FOXA1 SRX1161207 | T-47D Breast | 101 / 11152 (0.9%) | 4722 / 111520 (4.2%) | −91.2 | −89.4 | 0.21 |
| RBFOX2 SRX3322782 | K-562 Blood | 1210 / 11152 (10.9%) | 6234 / 111520 (5.6%) | −91.2 | −89.3 | 1.94 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 231 / 11152 (2.1%) | 6996 / 111520 (6.3%) | −91.2 | −89.3 | 0.33 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 240 / 11152 (2.2%) | 7137 / 111520 (6.4%) | −91.1 | −89.2 | 0.34 |
| EP300 SRX2194265 | SUM 159PT Breast | 407 / 11152 (3.6%) | 9679 / 111520 (8.7%) | −91.1 | −89.2 | 0.42 |
| ESR1 SRX4367192 | MCF-7 Breast | 542 / 11152 (4.9%) | 11591 / 111520 (10.4%) | −91.0 | −89.1 | 0.47 |
| NR3C1 SRX10976921 | A549 Lung | 179 / 11152 (1.6%) | 6125 / 111520 (5.5%) | −90.9 | −89.1 | 0.29 |
| KAT6A DRX366109 | 293 Kidney | 1314 / 11152 (11.8%) | 7005 / 111520 (6.3%) | −90.9 | −89.1 | 1.88 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 438 / 11152 (3.9%) | 1256 / 111520 (1.1%) | −90.9 | −89.1 | 3.49 |
| FOXA1 SRX100477 | Hep G2 Liver | 299 / 11152 (2.7%) | 8056 / 111520 (7.2%) | −90.9 | −89.0 | 0.37 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 169 / 11152 (1.5%) | 5952 / 111520 (5.3%) | −90.9 | −89.0 | 0.28 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 486 / 11152 (4.4%) | 10799 / 111520 (9.7%) | −90.9 | −89.0 | 0.45 |
| CDK9 SRX20230570 | Ishikawa Uterus | 1079 / 11152 (9.7%) | 5303 / 111520 (4.8%) | −90.9 | −89.0 | 2.03 |
| FOXA1 SRX3923519 | MCF-7 Breast | 157 / 11152 (1.4%) | 5739 / 111520 (5.1%) | −90.9 | −89.0 | 0.27 |
| MYC SRX13134693 | 293 Kidney | 832 / 11152 (7.5%) | 3615 / 111520 (3.2%) | −90.8 | −88.9 | 2.30 |
| NR3C1 SRX19024870 | MCF-7 Breast | 82 / 11152 (0.7%) | 4332 / 111520 (3.9%) | −90.7 | −88.9 | 0.19 |
| TEAD1 SRX716558 | SF268 Neural | 125 / 11152 (1.1%) | 5160 / 111520 (4.6%) | −90.7 | −88.8 | 0.24 |
| KMT2C SRX1787675 | MCF-7 Breast | 238 / 11152 (2.1%) | 7082 / 111520 (6.4%) | −90.4 | −88.6 | 0.34 |
| ESR1 SRX4451213 | MCF-7 Breast | 272 / 11152 (2.4%) | 7618 / 111520 (6.8%) | −90.4 | −88.6 | 0.36 |
| FOXA1 SRX190181 | A549 Lung | 188 / 11152 (1.7%) | 6251 / 111520 (5.6%) | −90.2 | −88.4 | 0.30 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 259 / 11152 (2.3%) | 7405 / 111520 (6.6%) | −90.2 | −88.3 | 0.35 |
| FOXA1 SRX3923515 | MCF-7 Breast | 146 / 11152 (1.3%) | 5523 / 111520 (5.0%) | −90.1 | −88.3 | 0.26 |
| KAT6A DRX366108 | 293 Kidney | 1095 / 11152 (9.8%) | 5434 / 111520 (4.9%) | −90.1 | −88.2 | 2.02 |
| Epitope tags SRX2745846 | MCF 10A Breast | 172 / 11152 (1.5%) | 5976 / 111520 (5.4%) | −90.1 | −88.2 | 0.29 |
| ARID1A SRX5679788 | 12Z Others | 106 / 11152 (1.0%) | 4782 / 111520 (4.3%) | −90.0 | −88.1 | 0.22 |
| JUN SRX2355072 | HAEC Cardiovascular | 348 / 11152 (3.1%) | 8759 / 111520 (7.9%) | −89.8 | −88.0 | 0.40 |
| ESR1 SRX10365558 | MCF-7 Breast | 183 / 11152 (1.6%) | 6144 / 111520 (5.5%) | −89.6 | −87.7 | 0.30 |
| JADE3 DRX234809 | 293 Kidney | 652 / 11152 (5.8%) | 2492 / 111520 (2.2%) | −89.5 | −87.7 | 2.62 |
| SETD1A SRX23734379 | MOLM-13 Blood | 774 / 11152 (6.9%) | 3261 / 111520 (2.9%) | −89.5 | −87.6 | 2.37 |
| NR3C1 SRX1161182 | ZR-75-1 Breast | 56 / 11152 (0.5%) | 3748 / 111520 (3.4%) | −89.4 | −87.6 | 0.15 |
| FOXA1 SRX3931031 | MCF-7 Breast | 119 / 11152 (1.1%) | 5005 / 111520 (4.5%) | −89.2 | −87.3 | 0.24 |
| EP300 SRX717860 | HeLa Uterus | 166 / 11152 (1.5%) | 5842 / 111520 (5.2%) | −89.2 | −87.3 | 0.28 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 247 / 11152 (2.2%) | 7175 / 111520 (6.4%) | −89.0 | −87.2 | 0.34 |
| NR3C1 SRX10977357 | A549 Lung | 160 / 11152 (1.4%) | 5733 / 111520 (5.1%) | −89.0 | −87.2 | 0.28 |
| CDK9 SRX20230567 | Ishikawa Uterus | 1115 / 11152 (10.0%) | 5606 / 111520 (5.0%) | −88.9 | −87.1 | 1.99 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 70 / 11152 (0.6%) | 4034 / 111520 (3.6%) | −88.9 | −87.1 | 0.17 |
| ZEB1 SRX13298923 | MCF-7 Breast | 108 / 11152 (1.0%) | 4789 / 111520 (4.3%) | −88.9 | −87.1 | 0.23 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 343 / 11152 (3.1%) | 8649 / 111520 (7.8%) | −88.8 | −87.0 | 0.40 |
| Epitope tags SRX15725652 | 293 Kidney | 1167 / 11152 (10.5%) | 5986 / 111520 (5.4%) | −88.8 | −86.9 | 1.95 |
| ESR1 SRX3110725 | MCF-7 Breast | 248 / 11152 (2.2%) | 7183 / 111520 (6.4%) | −88.7 | −86.9 | 0.35 |
| CREBBP SRX359409 | 293 Kidney | 1002 / 11152 (9.0%) | 4811 / 111520 (4.3%) | −88.7 | −86.9 | 2.08 |
| FOXA1 SRX13814018 | 5637 Others | 171 / 11152 (1.5%) | 5912 / 111520 (5.3%) | −88.7 | −86.9 | 0.29 |
| STAT3 SRX150536 | MCF 10A Breast | 298 / 11152 (2.7%) | 7959 / 111520 (7.1%) | −88.7 | −86.9 | 0.37 |
| AR SRX9109110 | MDA-MB-453 Breast | 514 / 11152 (4.6%) | 11101 / 111520 (10.0%) | −88.7 | −86.8 | 0.46 |
| ESR1 SRX10365534 | MCF-7 Breast | 75 / 11152 (0.7%) | 4131 / 111520 (3.7%) | −88.7 | −86.8 | 0.18 |
| SMARCA4 SRX5982340 | A549 Lung | 101 / 11152 (0.9%) | 4646 / 111520 (4.2%) | −88.6 | −86.8 | 0.22 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 255 / 11152 (2.3%) | 7286 / 111520 (6.5%) | −88.6 | −86.7 | 0.35 |
| NR3C1 SRX8520802 | HCC1187 Breast | 197 / 11152 (1.8%) | 6346 / 111520 (5.7%) | −88.5 | −86.6 | 0.31 |
Showing first 500 of 16265 rows.